July 20-28, 2016
![](https://phgkb.cdc.gov/GAPPKB/images/Whats_new.jpg)
Last Updated: Jul 21, 2016
- Comparison of effectiveness of treatment of patients with sporadic and germline BRCA1-related ovarian cancer.
Szatkowski Wiktor, et al. Ginekologia polska 2016 0 (6) 422-5 - Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
George Angela et al. Scientific reports 2016 629506 - Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
Staudigl Christine et al. BMC cancer 2016 16436 - Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
Gargiulo Piera, et al. BMC cancer 2016 0 (1) 375 - Drawing the Line in Risk-Reducing Gynecologic Surgery in Women With a BRCA Mutation.
Leath Charles A et al. JAMA oncology 2016 Jun - Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.
Shu Catherine A et al. JAMA oncology 2016 Jun - Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
Murphy Brittany L, et al. Annals of surgical oncology 2016 6 - Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival.
Biglia Nicoletta, et al. Ecancermedicalscience 2016 0 639 - Drawing the Line in Risk-Reducing Gynecologic Surgery in Women With a BRCA Mutation
CA Leath et al, JAMA Oncology, July 1, 2016 - Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations
CA Shu et al, JAMA Oncology, July 1, 2016 - Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
Chiba Akiko et al. Annals of surgical oncology 2016 Jun - The integration of BRCA testing into oncology clinics.
Percival Natalie et al. British journal of nursing (Mark Allen Publishing) 2016 Jun 25(12) 690-4 - A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial.
Roviello Giandomenico, et al. Future oncology (London, England) 2016 6 - Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?
van Tilborg Theodora C, et al. Menopause (New York, N.Y.) 2016 6 - Germline Mutations in DNA Repair Genes May Predict Neoadjuvant Therapy Response in Triple Negative Breast Patients.
Spugnesi Laura, et al. Genes, chromosomes & cancer 2016 6
![CDC Resources with and image of DNA](https://phgkb.cdc.gov/GAPPKBImage/images/CDC_resources.jpg)
![Seletced Insights & Reviews with various images of researchers in labortory environments](https://phgkb.cdc.gov/GAPPKBImage/images/discovery.jpg)
- Human (39)
- Pathogen (0)
![Epidemiology with an image of a crowd of people with a double helix](https://phgkb.cdc.gov/GAPPKBImage/images/epidemiology.jpg)
- Human (468)
- Pathogen (0)
![Translational Research with two images of people talking to a genetic counselor and an image of a hand with wrapped sequecing around it](https://phgkb.cdc.gov/GAPPKBImage/images/translational.jpg)
- Human (133)
- Pathogen (0)
![Evidence Synthesis with an image of sequencing and a double helix](https://phgkb.cdc.gov/GAPPKBImage/images/evidence.jpg)
![Practice & Implementation with images of people taking to a doctor and a nurse examining a child](https://phgkb.cdc.gov/GAPPKBImage/images/practice.jpg)
- Huamn (26)
- Pathogen (0)
No hay comentarios:
Publicar un comentario